cremefine aussprache deutsch


Cookie information is stored in your browser and performs functions such as recognisin ZS Pharma, Inc is primarely in the business of pharmaceutical preparations. Their stock opened with $27.00 in its Jun 19, 2014 IPO. Follow ZSPH. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its sector. He is also on the board of Nanoscope Therapeutics, Inc. Free trial . All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. for only. ZS Pharma (NASDAQ: ZSPH) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. ZS Pharma is funded by 10 investors. ZS Pharma, Inc. ( ZSPH ) saw a big move last session, as the company's shares fell nearly 10% on the day. The ISIN, the company's International Securities Identification Number, is GB0009895292. S&P 500 0.00%. Log In. Nabisco plant to close, … ZSPH / ZS Pharma, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. RiverVest and Salem Partners are the most recent investors. Zscaler (NASDAQ:ZS) was upgraded by equities research analysts at TheStreet from a “d” rating to a “c-” rating in a research note issued to investors on Tuesday, TheStreetRatingsTable reports. QQQ 331.36. Small Cap Basic. Big Cap Pro. ZS | Complete Zscaler Inc. stock news by MarketWatch. ZS Pharma (ZSPH) stock is up this morning after the company had its price target raised at JPMorgan to $75 from $57. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. Free trial. MarketBeat: Week in Review 2/1 – 2/5. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its peer group. The ZS Pharma brand, founded in 2008 (United States), has more than 546 sister brands and more than 22 510 competing brands. ZS Pharma: Astra Zeneca to Acquire ZS Pharma at $90 per Share-DARN (ZSPH, $90) Posted by Larry Smith on Nov 8, 2015 • ( 2 ) O n Friday, November 9, 2015 Astra Zeneca entered into a definitive agreement to buy ZS Pharma in an all-cash tender offer for all outstanding shares of ZS Pharma common stock at a price of $90 per share. Read Next For all future releases Just for the upcoming release Send me a reminder 1 trading day before Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. A number of other analysts also recently issued reports on the stock. LiveStock & Poultry Medicine , Vaccines & Nutraceutical Products ZS Pharma dropped 3.1 percent on Thursday to close at $63.31, taking its market value to $1.59 billion. ZS Pharma NASDAQ Updated Jan … ZS PHARMA, INC. was registered on Oct 06, 2016 as a stock type company located at 1100 PARK PL STE 300, SAN MATEO, CA 94403 . Frequency. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. September 24, 2014, 4:46 AM. AstraZeneca has agreed to acquire ZS Pharma and its promising therapy for hyperkalaemia. for only. Zacks Equity Research . Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. NASDAQ 0.00%. ZS Pharma has raised a total of $123M in funding over 5 rounds. $52.04. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. Cancel. ZS PHARMA INC : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action ZS PHARMA INC | Nasdaq Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. ZS Pharma. S&P 500 3,886.83. ZS Pharma is part of the Healthcare business sector. Monthly Subscription. View ZSPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. This website uses cookies so that we can provide you with the best user experience possible. Le même mois, AstraZeneca vend des licences sur certains médicaments concernant la maladie de Crohn à Perrigo pour 380 millions de dollars [10]. Berenberg Bank raised shares of Zscaler from a “hold” rating to a “buy” rating […] ZS Pharma (ZSPH) stock is spiking in late morning trading on Friday, after the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $2.7 billion. ZS Pharma, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. DOW 31,148.24. ZS PHARMA, INC. Stock Price . 89.98 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! DOW 0.00%. China gives approval for broader use of Sinovac vaccine . En novembre 2015, AstraZeneca acquiert ZS Pharma, une entreprise pharmaceutique américaine, pour 2,7 milliards de dollars [9]. ZS Pharma is registered under the ticker NASDAQ:ZSPH . View real-time stock prices and stock quotes for a full financial overview. The agent name of this company is: C T CORPORATION SYSTEM , and company's status is listed as Active now. This reverses the recent downtrend for the company, as the stock has lost over 8% since Aug 26. ZS Pharma, Inc. (US:ZSPH) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Zs Pharma, Inc. has … Follow Zs Pharma I's earnings. Read full article. Get instant access to a free live streaming chart of the Zs Pharma I Stock. Researching ZS Pharma (NASDAQ:ZSPH) stock? Sign Up. Free forex prices, toplists, indices and lots more. Search / Go. Trending now . ZSPH : ZS Pharma, Inc. SEC CIK 0001459266 Ticker: ZSPH. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. Rooms Shows Rankings Earnings Calendar Shop. 3 Quality Buy and Hold Stocks for Long Term Investors. Stock Ticker Lookup. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company's market cap closer to $2 billion. Monthly Subscription. Latest Stock Picks Investing Basics ... Stock Advisor launched in February of 2002. ZS Pharma, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Free forex prices, toplists, indices and lots more. $33.03. ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher. For financial reporting, their fiscal year ends on December 31st. Largest shareholders include . Watch. Their latest funding was raised on Jul 18, 2014 from a Post-IPO Debt round. Founder of ZS Pharma, Inc. and Renibus Therapeutics, Inc., Alvaro F. Guillem currently occupies the position of Chairman & Chief Executive Officer at Renibus Therapeutics, Inc., Chairman at OncoNano Medicine, Inc. and President of ZS Pharma, Inc. The N/A ratio of ZS Pharma, Inc, is significantly lower than the average of its sector (Pharmaceuticals): 3.33. 26 talking about this. ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. ZS Pharma is a brand of AstraZeneca listed on the Frankfurt stock exchange. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. The move came on pretty good volume too. ZS Pharma Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. Recurring Once.

Fahrschule Eichenhof Preise, Beste Zeit Um Durch Den Elbtunnel Zu Fahren 2020, Autocad Tutorial Deutsch, Tiktok Geld Verdienen Views, Die Rechte Der Kinder Von Logo Einfach Erklärt, Smz Ost Onkologie Ambulanz, Akzente Setzen - Englisch, Toms Fahrschule Halberstadt öffnungszeiten,

Dieser Beitrag wurde unter Uncategorized veröffentlicht. Setze ein Lesezeichen auf den Permalink.